Stock-Based Compensation - Schedule of Activity Under RSUs (Details) - Restricted Stock Units (RSUs) |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
$ / shares
shares
| |
| RSUs | |
| Beginning balance (in shares) | shares | 8,519,973 |
| Granted (in shares) | shares | 279,688 |
| Vested (in shares) | shares | (126,942) |
| Forfeited (in shares) | shares | (1,043,220) |
| Ending balance (in shares) | shares | 7,629,499 |
| Vested and unissued (in shares) | shares | 0 |
| Non-vested (in shares) | shares | 7,629,499 |
| Weighted- Average Grant Date Fair Value Per RSU | |
| Beginning balance (in dollars per share) | $ / shares | $ 1.95 |
| Granted (in dollars per share) | $ / shares | 0.64 |
| Vested (in dollars per share) | $ / shares | 3.61 |
| Forfeited (in dollars per share) | $ / shares | 1.04 |
| Ending balance (in dollars per share) | $ / shares | 2.00 |
| Vested and unissued (in dollars per share) | $ / shares | |
| Non-vested (in dollars per share) | $ / shares | $ 2.00 |
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited In Period, Weighted Average Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Outstanding, Weighted Average Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Unissued, Outstanding, Number No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested And Unissued, Weighted Average Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|